129 related articles for article (PubMed ID: 10843282)
1. Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression.
Ijiri R; Tanaka Y; Kato K; Misugi K; Nishihira H; Toyoda Y; Kigasawa H; Nishi T; Takeuchi M; Aida N; Momoi T
Am J Surg Pathol; 2000 Jun; 24(6):807-15. PubMed ID: 10843282
[TBL] [Abstract][Full Text] [Related]
2. Maturation of mass-screened localized adrenal neuroblastoma.
Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
[TBL] [Abstract][Full Text] [Related]
3. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.
Nakagawara A; Nakamura Y; Ikeda H; Hiwasa T; Kuida K; Su MS; Zhao H; Cnaan A; Sakiyama S
Cancer Res; 1997 Oct; 57(20):4578-84. PubMed ID: 9377572
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
5. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
[TBL] [Abstract][Full Text] [Related]
7. Composite ganglioneuroblastoma. An assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy.
Bove KE; McAdams AJ
Arch Pathol Lab Med; 1981 Jun; 105(6):325-30. PubMed ID: 6894529
[TBL] [Abstract][Full Text] [Related]
8. The late recurrence of ganglioneuroma 21 years after initial presentation with neuroblastoma.
Okita Y; Narita Y; Yoshida A; Miyakita Y; Ohno M; Saio M; Yoshimi N; Shibui S
Pediatr Hematol Oncol; 2012 Oct; 29(7):647-51. PubMed ID: 22966943
[TBL] [Abstract][Full Text] [Related]
9. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression.
Kitanaka C; Kato K; Ijiri R; Sakurada K; Tomiyama A; Noguchi K; Nagashima Y; Nakagawara A; Momoi T; Toyoda Y; Kigasawa H; Nishi T; Shirouzu M; Yokoyama S; Tanaka Y; Kuchino Y
J Natl Cancer Inst; 2002 Mar; 94(5):358-68. PubMed ID: 11880474
[TBL] [Abstract][Full Text] [Related]
10. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
11. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
12. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
[TBL] [Abstract][Full Text] [Related]
13. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma.
Ikeda H; Hirato J; Akami M; Suzuki N; Takahashi A; Kuroiwa M; Matsuyama S
Am J Surg Pathol; 1996 Jun; 20(6):649-55. PubMed ID: 8651343
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
Lonergan GJ; Schwab CM; Suarez ES; Carlson CL
Radiographics; 2002; 22(4):911-34. PubMed ID: 12110723
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous Maturation of Neuroblastoma to Ganglioneuroma: Two Case Studies.
Yao ZG; Liu XM; Qin YJ
Fetal Pediatr Pathol; 2016; 35(6):410-415. PubMed ID: 27362946
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
[TBL] [Abstract][Full Text] [Related]
17. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
Ariyoshi N
J UOEH; 1993 Dec; 15(4):251-66. PubMed ID: 8265887
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
Alexander N; Sullivan K; Shaikh F; Irwin MS
Pediatr Blood Cancer; 2018 May; 65(5):e26964. PubMed ID: 29369484
[TBL] [Abstract][Full Text] [Related]
19. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
[TBL] [Abstract][Full Text] [Related]
20. The International Neuroblastoma Pathology Classification (the Shimada system).
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
